Fundraising FoxAquinnah Pharmaceuticals
Cambridge, US · 2 known investors
Find your way into Aquinnah Pharmaceuticals
Sign up to find every way you can get introduced to Aquinnah Pharmaceuticals
- Your email: who you already know at Aquinnah Pharmaceuticals, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Aquinnah Pharmaceuticals team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Aquinnah Pharmaceuticals develops oral small-molecule therapeutics targeting pathologic biomolecular condensates, such as stress granules formed by RNA-binding proteins, to slow neurodegenerative diseases including ALS and Alzheimer's disease. The company focuses on drug discovery for neurological disorders with high unmet medical need.
Founders & leadership
Investors · 2
Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M
How we know: Pfizer Venture Investments's portfolio page · the VCSheet dataset · Not right? Tell us
AbbViereportedCambridge · $300K – $3M
How we know: a partner's Signal profile · Not right? Tell us
In the news
Frequently asked questions
- What does Aquinnah Pharmaceuticals do?
- Aquinnah Pharmaceuticals develops oral small-molecule therapeutics targeting pathologic biomolecular condensates, such as stress granules formed by RNA-binding proteins, to slow neurodegenerative diseases including ALS and Alzheimer's disease. The company focuses on drug discovery for neurological disorders with high unmet medical need.
- Who founded Aquinnah Pharmaceuticals?
- Aquinnah Pharmaceuticals was founded by Benjamin Wolozin.
- Who are Aquinnah Pharmaceuticals's investors?
- Aquinnah Pharmaceuticals's investors include Pfizer Venture Investments, AbbVie.
- Where is Aquinnah Pharmaceuticals headquartered?
- Aquinnah Pharmaceuticals is headquartered in Cambridge, US.